Tistoryview
Disease&Treatment/Retina
Etiology, systemic symptoms, ophthalmic symptoms (uveitis, retinal vasculitis), diagnostic criteria, treatment, and prognosis of Behcet's disease
eye_doc 2025. 4. 21. 19:57👁 Behcet’s Disease – Systemic Autoimmune Disease with Ocular Involvement
Behcet’s disease is a multisystem inflammatory disorder
associated with HLA-B51 and potential triggers like HSV or heat-shock proteins.
Its hallmark is recurrent oral ulcers, but it also affects the eyes, skin, vasculature, CNS, and GI tract.
✅ Diagnostic Criteria
SystemCriteria
Japan | Major (oral, genital ulcers, skin, eye) + minor criteria → Complete or Incomplete |
ISG (International Study Group) | 3+ oral ulcers/year + 2 of genital ulcers, eye lesions, skin, pathergy test |
✅ Systemic Manifestations
SystemFeature
Oral | Painful ulcers, most common |
Genital | May scar |
Skin | Erythema nodosum, acneiform lesions |
GI | Ileocecal ulcers |
Vascular | Venous thrombosis > arterial (pulmonary aneurysm rare but fatal) |
CNS | Meningoencephalitis, cranial nerve palsies |
✅ Ocular Involvement
SiteFindings
Anterior | Hypopyon uveitis, often without conjunctival injection (Cold hypopyon) |
Posterior | Retinal vasculitis, vascular occlusion, CNV, optic atrophy, RD |
✅ Treatment Summary
- Steroids (topical/systemic)
- Cyclosporine / Tacrolimus – for T-cell suppression
- Immunomodulators: MTx, Azathioprine, Infliximab
- Colchicine / Thalidomide – mucocutaneous lesions
Thalidomide: strictly contraindicated in women of childbearing potential
✅ Prognosis
- Many patients lead normal lives with treatment
- Visual prognosis depends on early detection of ocular Behcet’s
- 10-year disease activity tends to decline naturally